A Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Status:
Completed
Trial end date:
2020-08-28
Target enrollment:
Participant gender:
Summary
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study of IMR-687 in Adult Patients
with Sickle Cell Anaemia (Homozygous HbSS or Sickle-β0 Thalassemia).